Methyl-β-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats
Authors:
- 1 March 1995
- journal article
- Published by Elsevier in Brain Research
- Vol. 675 (1-2) , 279-288
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS 23891)
This publication has 32 references indexed in Scilit:
- Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic?Neurobiology of Aging, 1992
- The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brainNeurobiology of Aging, 1992
- Novel S‐Adenosylmethionine‐Dependent Indole‐N‐Methylation of β‐Carbolines in Brain Particulate FractionsJournal of Neurochemistry, 1992
- β-Carbolines and Tetrahydroisoquinolines: Detection and Function in MammalsPlanta Medica, 1991
- Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTPBiochemical and Biophysical Research Communications, 1987
- New Designs in Analysis of VarianceAnnual Review of Psychology, 1987
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Multiple Comparisons for Orthogonal Contrasts: Examples and TablesTechnometrics, 1982
- Harmaline: A competitive inhibitor of Na Ion in the (Na++K+)-ATPase systemThe Journal of Membrane Biology, 1973